MIRAGEN THERAPEUTICS INC - COM (MGEN)

CUSIP: 60463E103

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
12,179,863
Share change
-895,644
Total reported value
$25,024,619
Price per share
$2.05
Number of holders
44
Value change
-$2,390,626
Number of buys
18
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 60463E103?
CUSIP 60463E103 identifies MGEN - MIRAGEN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MIRAGEN THERAPEUTICS INC - COM (MGEN) as of Q2 2019

As of 30 Jun 2019, MIRAGEN THERAPEUTICS INC - COM (MGEN) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,179,863 shares. The largest 10 holders included Atlas Venture Advisors, Inc., FMR LLC, 683 Capital Management, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, NORTHERN TRUST CORP, and DIMENSIONAL FUND ADVISORS LP. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.